Day: January 9, 2024

The purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings. … If a patient’s HER2-positive advanced breast cancer has progressed during or after second-line or greater HER2-targeted …